| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/17/2008 | US20080015137 Methods and Compositions for Targeting Macromolecules Into the Nucleus |
| 01/17/2008 | US20080014646 Method of presuming domain linker region of protein |
| 01/17/2008 | US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 01/17/2008 | US20080014635 Methods of increasing protein expression levels |
| 01/17/2008 | US20080014624 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs |
| 01/17/2008 | US20080014613 Prokaryotic collagen-like proteins and uses thereof |
| 01/17/2008 | US20080014609 Methods for Obtaining Thermostable Enzymes, Dna Polymerase I Variants from Thermus Aquaticus Having New Catalytic Activities, Methods for Obtaining the Same, and Applications to the Same |
| 01/17/2008 | US20080014608 Modified Promoter |
| 01/17/2008 | US20080014593 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 01/17/2008 | US20080014590 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 01/17/2008 | US20080014588 Compositions and methods for detecting multidrug resistant strains of M. tuberculosis having mutations in genes of the mutT family |
| 01/17/2008 | US20080014586 Identification of a receptor controlling migration and metastasis of skin cancer cells |
| 01/17/2008 | US20080014585 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 01/17/2008 | US20080014270 Methods for improved lipid metabolism and basal metabolic rate with lactoferrin |
| 01/17/2008 | US20080014215 Animal Bioreactors |
| 01/17/2008 | US20080014212 Cloned genomes of infectious hepatitis C viruses and uses thereof |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | DE102006032634A1 Verfahren zur Herstellung von L-Aminosäuren A method for producing L-amino acids |
| 01/17/2008 | DE102006031962A1 Amidiertes Insulin Glargin Amidated insulin glargine |
| 01/17/2008 | DE102006031955A1 Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende Process for the preparation of insulin analogues with dibasic B chain end |
| 01/17/2008 | CA2659392A1 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
| 01/17/2008 | CA2658391A1 Dna encoding ring zinc-finger protein and the use of the dna in vectors and bacteria and in plants |
| 01/17/2008 | CA2658260A1 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells |
| 01/17/2008 | CA2657665A1 Method and compositions for treating stroke with fever |
| 01/17/2008 | CA2657521A1 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for non-clostridial toxin target cells |
| 01/17/2008 | CA2657385A1 Cell death inducer |
| 01/17/2008 | CA2657310A1 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| 01/17/2008 | CA2657041A1 Method for producing insulin analogs having a dibasic b chain terminus |
| 01/17/2008 | CA2655042A1 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/16/2008 | EP1878805A2 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus |
| 01/16/2008 | EP1878797A2 Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same |
| 01/16/2008 | EP1878796A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878795A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878794A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878793A1 Novel protein and preventive/remedy for neurodegenerative disease such as polyglutamine disease using the same |
| 01/16/2008 | EP1878745A1 Humanin receptor or humanin-like polypeptide receptor |
| 01/16/2008 | EP1878744A1 Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878742A2 HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878439A2 Actinobacillus pleuropneumoniae virulence genes |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1877580A2 Lawsonia intracellularis immunological proteins |
| 01/16/2008 | EP1877563A2 Plants containing a heterologous flavohemoglobin gene and methods of use thereof |
| 01/16/2008 | EP1877558A1 Preparation of soluble n-protein/truncated p-protein complexes or n-proteins soluble in a virus of the paramyxoviridae family and use thereof in vaccines |
| 01/16/2008 | EP1877549A2 Hiv vaccine |
| 01/16/2008 | EP1877545A2 Mammalian expression systems |
| 01/16/2008 | EP1877443A2 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 01/16/2008 | EP1877440A2 Recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 01/16/2008 | EP1877439A2 Il-21 variants |
| 01/16/2008 | EP1877438A2 Method of treating eye injury with local administration of a vegf inhibitor |
| 01/16/2008 | EP1877435A2 Glucagon-like-peptide-2 (glp-2) analogues |
| 01/16/2008 | EP1877434A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 01/16/2008 | EP1877433A2 Vegf variants |
| 01/16/2008 | EP1877432A2 Stabilization of cardiac troponin |
| 01/16/2008 | EP1877431A1 Antiviral peptide against hepatitis c virus |
| 01/16/2008 | EP1877430A2 Compounds and methods for modulating cadherin-mediated processes |
| 01/16/2008 | EP1877429A2 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| 01/16/2008 | EP1877428A2 Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer |
| 01/16/2008 | EP1877427A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 01/16/2008 | EP1877426A2 Novel method for preventing or treating m tuberculosis infection |
| 01/16/2008 | EP1877425A2 Fluorescent proteins and uses thereof |
| 01/16/2008 | EP1877420A1 Combination therapy in the treatment of cancer |
| 01/16/2008 | EP1877088A2 Vaccine against pandemic strains of influenza viruses |
| 01/16/2008 | EP1877073A2 Non-cytotoxic protein conjugates |
| 01/16/2008 | EP1711511B1 Method for crystallization of proteins using polysaccharides |
| 01/16/2008 | EP1613644A4 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 01/16/2008 | EP1601691B1 Shrew paralytic peptide for use in neuromuscular therapy |
| 01/16/2008 | EP1599231A4 Treatment of pain through expression of opioid receptors |
| 01/16/2008 | EP1594529A4 Analogues of glp-1 |
| 01/16/2008 | EP1513877B1 Marker for stem cells and its use |
| 01/16/2008 | EP1351979B1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1255562B1 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 01/16/2008 | EP1228193B1 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1098961B1 Interferon inducing genetically engineered attenuated viruses |
| 01/16/2008 | EP1077998B1 Labelled glutamine and lysine analogues |
| 01/16/2008 | EP1032587B1 Novel exendin agonist compounds |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | EP0991761B1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107364A Plants having increased yield and a method for making the same |
| 01/16/2008 | CN101107361A Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 01/16/2008 | CN101107360A HCV F protein and uses thereof |
| 01/16/2008 | CN101107359A A method of prime-boost vaccination |
| 01/16/2008 | CN101107268A Specific binding members for NGF |
| 01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 01/16/2008 | CN101107266A Peptides with neuropeptide-2 receptor (Y2R) agonist activity |
| 01/16/2008 | CN101107264A C5a receptor antagonists |
| 01/16/2008 | CN101104856A Series of non-viral vectors and pharmaceutical composition containing the same |
| 01/16/2008 | CN101104853A Small rat Dnaic2 gene order |
| 01/16/2008 | CN101104852A Human new gene LOC344967 correlated with nasopharyngeal carcinoma and coding protein product thereof |
| 01/16/2008 | CN101104851A Preparation for antiviral protein CV-N |
| 01/16/2008 | CN101104641A Fusion protein of PRRS virus used as swine procreation and respiratory tract syndrome vaccine |
| 01/16/2008 | CN101104638A Solid phase synthetic technique for thymosin alpha1 |